Total parathyroidectomy improves survival of hemodialysis patients with secondary hyperparathyroidism

Journal of Nephrology

Volumn 25, Issue 5, 2012, Pages 755-763

  Iwamoto, Noriyuki ^a   Sato, Nodoka ^a   Nishida, Masaya ^a   Hashimoto, Tetsuya ^a   Kobayashi, Hiroyuki ^a   Yamasaki, Satoru ^a   Ono, Toshihiko ^a   Nishimura, Masato ^a   Tokoro, Toshiko ^a   Sakoda, Chikako ^a   Murakawa, Mayuko ^a   Okino, Koji ^a   Okamoto, Yuu ^a   Imai, Ryo ^a   Adachi, Naoto ^a   Ninomiya, Kanji ^b   Mabuchi, Hisao ^b   Koyama, Masaki ^c   Nakanouchi, Tsuneyuki ^d   Iseki, Kunitoshi ^e  

^a Urology Division   (Japan)

^b Mabuchi Clinic   (Japan)

^c Nishijin Hospital   (Japan)

^d KYOTO FIRST RED CROSS HOSPITAL   (Japan)

^e UNIVERSITY HOSPITAL OF THE RYUKYUS   (Japan)

Author keywords

Hemodialysis; Parathyroidectomy; Secondary hyperparathyroidism

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIUM; CREATININE; HEMOGLOBIN; PARATHYROID HORMONE; PHOSPHATE;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; COMPARATIVE STUDY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE FREE SURVIVAL; FEMALE; HEART ATRIUM FIBRILLATION; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERPARATHYROIDISM; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL; SURVIVAL RATE;

ADULT; AGED; BIOLOGICAL MARKERS; CALCIUM; CARDIOVASCULAR DISEASES; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PARATHYROID HORMONE; PARATHYROIDECTOMY; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 84866994213     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: 10.5301/jn.5000056     Document Type: Article

References (37)

1. Goodman WG, Goldin J, Kuizon BD, et al. Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med. 2000;342(20):1478-1483.
2. Block GA, Klassen PS, Lazarus GM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, morbidity in maintenance hemodialysis. J Am Soc Nephrol. 2004;15(8):2208-2218.
3. Slinin Y, Foley RN, Collins AJ. Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol. 2005;16(6):1788-1793.
4. Coen G, Manni M, Mantella D, et al. Are PTH serum levels predictive of coronary calcifications in haemodialysis patients? Nephrol Dial Transplant. 2007;22(11):3262-3267.
5. Neves KR, Graciolli FG, dos Reis LM, et al. Vascular calcification: contribution of parathyroid hormone in renal failure. Kidney Int. 2007;71(12):1262-1270.
6. Goldsmith DJ, Covic AA, Venning MC, Ackrill P. Blood pressure reduction after parathyroidectomy for secondary hyperparathyroidism: further evidence implicating calcium homeostasis in blood pressure regulation. Am J Kidney Dis. 1996;27(6):819-825.
7. Coen G, Calabria S, Bellinghieri G, et al. Parathyroidectomy in chronic renal failure: short and long-term results on parathyroid function, blood pressure and anemia. Nephron. 2001;88(2):149-155.
8. Yasunaga C, Nakamoto M, Matsuo K, Nishihara G, Yoshida T, Goya T. Effects of a parathyroidectomy on the immune system and nutritional condition in chronic dialysis patients with secondary hyperparathyroidism. Am J Surg. 1999;178(4):332-336.
9. Chou F-F, Lee CH, Lee CT. Muscle force and bone mineral density after parathyroidectomy and subcutaneous autotransplantation for secondary hyperparathyroidism. World J Surg. 1999;23(5):452-457 [discussion: 456-457].
10. Chow KM, Szeto CC, Kum LCC, et al. Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol. 2003;16(6):878-885.
11. Esposito MG, Cesare CM, De Santo RM, et al. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism. J Nephrol. 2008;21(Suppl 13):S92-S96.
12. Chou FF, Chen JB, Hsieh KC, Hsieh KC, Liou CW. Cognitive changes after parathyroidectomy in patients with secondary hyperparathyroidism. Surgery. 2008;143(4):526-532.
13. Kestenbaum B, Andress DL, Schwartz SM, et al. Survival following parathyroidectomy among United States dialysis patients. Kidney Int. 2004;66(5):2010-2016.
14. Dussol B, Morand P, Martinat C, et al. Influence of parathyroidectomy on mortality in hemodialysis patients: a prospective observational study. Ren Fail. 2007;29(5):579-586.
15. Costa-Hong V, Jorgetti V, Gowdak LH, Moyses RMA, Krieger EM, De Lima JJ. Parathyroidectomy reduces cardiovascular events and mortality in renal hyperparathyroidism. Surgery. 2007;142(5):699-703.
16. Guérin AP, London GM, Marchais SJ, Metivier F. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant. 2000;15(7):1014-1021.
17. Jono S, McKee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res. 2000;87(7):E10-E17.
18. Yang H, Curinga G, Giachelli CM. Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro. Kidney Int. 2004;66(6):2293-2299.
19. Moe SM, Duan D, Doehle BP, O'Neill KD, Chen NX. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int. 2003;63(3):1003-1011.
20. Zhang YB, Smogorzewski M, Ni Z, Massry SG. Altered cytosolic calcium homeostasis in rat cardiac myocytes in CRF. Kidney Int. 1994;45:1113-1119
21. Amann K, Ritz E, Wiest G, Klaus G, Mall G. A role of parathyroid hormone for the activation of cardiac fibroblasts in uremia. J Am Soc Nephrol. 1994;4(10):1814-1819.
22. Rodríguez-Ayala E, Avila-Díaz M, Foyo-Niembro E, Amato D, Ramirez-San-Juan E, Paniagua R. Effect of parathyroidectomy on cardiac fibrosis and apoptosis: possible role of aldosterone. Nephron Physiol. 2006;103(3):112-118.
23. Kawata T, Nagano N, Obi M, et al. Cinacalcet suppresses calcification of the aorta and heart in uremic rats. Kidney Int. 2008;74(10):1270-1277.
24. Gunther T, Chen ZF, Kim J, et al. Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature. 2000;406:199-203.
25. London GM, Gue'Rin AP, Marchais SJ. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant. 2003;18:1731-1740.
26. Wang AY, Wang M, Woo J. Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol. 2003;14:159-168.
27. Bleyer AJ, Burkart J, Piazza M, Russel G, Rohr M, Carr JJ. Changes in cardiovascular calcification after parathyroidectomy in patients with ESRD. Am J Kidney Dis. 2005;46:464-469.
28. Kauppila LI, Polak JF, Cupples LA, et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997;132:245-250.
29. Ubara Y, Tagami T, Nakanishi S, et al. Significance of minimodeling in dialysis patients with adynamic bone disease. Kidney Int. 2005;68:833-839.
30. Yajima A, Inaba M, Tominaga Y, et al. Bone formation by minimodeling is more active than remodeling after parathyroidectomy. Kidney Int. 2008;74:775-781.
31. Raggi P, Boulay A, Chasan-Taber S. Cardiac calcification in adult hemodialysis patients: a link between end-stage renal disease and cardiovascular disease? J Am Coll Cardiol. 2002;39:695-701.
32. Saleh FN, Schirmer H, Sundsfjord J, et al. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003;24:2054-2060.
33. Lomonte C, Derosa C, Vernaglione L, et al. Serum parathyroid hormone and phosphate influence the levels of circulating CD34+ cells in uremia. J Nephrol. 2010;23:693-698.
34. Shoji T, Shinohara K, Kimoto E, et al. Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a hemodialysis population. Nephrol Dial Transplant. 2004;19:178-184.
35. Raggi P, Chertow GM, Torres PU, et al. The ADVANCE study: a randomized study to evaluate the effects of cinacalcet plus low-dose vitamin D on vascular calcification in patients on hemodialysis. Nephrol Dial Transplant. 2011;26:1327-1339.
36. Guerra R, Auyanet I, Fernåndez EJ, et al. Hypercalcemia secondary to persistent hyperparathyroidism in kidney transplant patients: analysis after a year with cinacalcet. J Nephrol. 2011;24:78-82.
37. Messa P, Cafforo C, Alfieri C. Calcium and phosphate changes after renal transplantation. J Nephrol. 2010;23:S175-S181